A Plasmodium berghei sporozoite-based vaccination platform against human malaria
© 2018, The Author(s). There is a pressing need for safe and highly effective Plasmodium falciparum (Pf) malaria vaccines. The circumsporozoite protein (CS), expressed on sporozoites and during early hepatic stages, is a leading target vaccine candidate, but clinical efficacy has been modest so far....
| Format: | Article |
|---|---|
| Language: | English |
| Published: |
Springer Nature
2021
|
| Online Access: | https://hdl.handle.net/1721.1/132162 |